Member Info for hasiba

Shetie...morning
Look at this link below of Barclays brockers reviews by the users....
I would advise you to avoid..
https://uk.trustpilot.com/review/barclaysstockbrokers.co.uk

Derampers no chance of 2p ....the only way is up..it is already touched the 2.40 support level and bounced up massively yesterday.

Rough sea though so avoid if you are unlucky seasickness sufferer ....

Time to BUY IN NOW
Very supporting technical analysis by Stoxline giving motif sp four stars with two arrows upwards.

Six month target.. 9.01 P
Twelve month target..12.85 P
resistance 1 ......P7.71
resistance 2..... P 11.0

High risk play but Massive gains by expert technical analysis

https://uk.investing.com/equities/motif-bio-plc-technical

“And there you have it. Sucked in like a moth to the flames“
Just for you...
https://m.youtube.com/watch?v=en1uwIzI3SE

Hello..hello..can I speak to Scotty...
Sorry I cannot hear..Oh nooooo.....
I hope he recovers soon..must be very sad to end like this and really not nice ,wetting himself..
So sorry..bye now

You missed the boat AGAIN!
Still time..just!

Warren Buffett has a saying about the stock market and investing in general:
“Be fearful when others are greedy and greedy when others are fearful.” Time and again, the value investor has used this philosophy to pounce on opportunities.
Motif perhaps one of them or....maybe not
Not selling and holding ....it may bounce up soon or what!?!
It’s only money after all....you cannot take it with you ,so spending it to help humanity with Iclaprim? I thought it’s a good reason
Remember if you don’t spend it then really it’s not yours..

https://www.marketscreener.com/MOTIF-BIO-PLC-21452909/news/Motif-Bio-Presents-New-Iclaprim-Data-at-ASM-Microbe-2019-28800757/

ScottP
Yes This is why I posted the link but you were focusing on three options instead?
GL said they had interesting conversations and they show partnership interests...though in the layers of fda decision of clear path forwards ...so it is not all doom and gloom(yet)!
I post this link again to listen to it from min 6 onwards...
https://www.proactiveinvestors.co.uk/companies/stocktube/13472/motif-bio-s-graham-lumsden-updates-on-fda-discussions-and-iclaprim-potential-13472.html

Dodger777 175
Prime 180
Withoutt 183
Hasiba 188
Klassic 190
Boyobach 192
Stockbuster 193
Hawkey 200
Broadband 205
Digby04 209

53Dodger777 175
Prime 180
Withoutt 183
Hasiba 188
Klassic 190
Boyobach 192
Stockbuster 193
Hawkey 200
Broadband 205
Digby04 209

JL....
You need blood uric acid to be controlled with medicine to prevent recurrence.
Avoid alcohol drink and fatty food and red meat,liver and shell fish.
Drink Plenty of water ...
Nasty painful condition when in acute phase
Hope you will recover soon....first 48 hours are the worst then improving afterwards

JL....
You need blood uric acid to be controlled with medicine to prevent recurrence.
Avoid alcohol drink and fatty food and red meat and shell fish.
Drink Plenty of water ...
Nasty painful condition when in acute phase
Hope you will recover soon....first 48 hours are the worst then improving afterwards

https://www.proactiveinvestors.co.uk/companies/stocktube/13472/motif-bio-s-graham-lumsden-updates-on-fda-discussions-and-iclaprim-potential-13472.html

With a SP at 2.8p...well undervalued and unjustified

.In all likelihood the present bod will be replaced/strengthening as they lost trust by all shareholders and their failure to achieve or prepare a proper nda for approval...they wasted time and huge resources. Once you lost trust..it is very hard to gain it again and rightly so in this case.
Andrew Powell appointment was not without meaning but imo to sell / or partnership motif with the best price possible to get Iclaprim new trial moving forwards and this will need time and funds that I doubt anybody would trust the current motif leadership in its current form to do this.
Iclaprim reached a far better position now to be approved and for a third party to fund a new trial is not a big issue for them to be rewarded massively in the future approval of Iclaprim.
We need to remember that the fda did not reject the application moving forwards but requested more data required of potential liver toxicity AR ...by another new trial so this is a big plus for a third party to come along and finish the work and gets the rewards in possible within 2 years...it makes more sense than abandoning the whole thing while you are at the last hurdle to pass the finishing line.
All now is underway on how much will the third party pay....or a partner to take control.

On average to develop a new drug and gets it approved..it costs near the $350 mil so why do this rather than spending fraction of this amount and buy motif!? Or partnership on favourable terms to get a massive rewards.
Just my humble views....Iclaprim will survive and get approved by a better hand.
ATB

.In all likelihood the present bod will be replaced/strengthening as they lost trust by all shareholders and their failure to achieve or prepare a proper nda for approval...they wasted time and huge resources. Once you lost trust..it is very hard to gain it again and rightly so in this case.
Andrew Powell appointment was not without meaning but imo to sell / or partnership motif with the best price possible to get Iclaprim new trial moving forwards and this will need time and funds that I doubt anybody would trust the current motif leadership in its current form to do this.
Iclaprim reached a far better position now to be approved and for a third party to fund a new trial is not a big issue for them to be rewarded massively in the future approval of Iclaprim.
We need to remember that the fda did not reject the application moving forwards but requested more data required of potential liver toxicity AR ...by another new trial so this is a big plus for a third party to come along and finish the work and gets the rewards in possible within 2 years...it makes more sense than abandoning the whole thing while you are at the last hurdle to pass the finishing line.
All now is underway on how much will the third party pay....or a partner to take control.

On average to develop a new drug and gets it approved..it costs near the $350 mil so why do this rather than spending fraction of this amount and buy motif!? Or partnership on favourable terms to get a massive rewards.
Just my humble views....Iclaprim will survive and get approved by a better hand.
ATB

As Bunks is not available I would give my summary speech and hope Bunks will do the big one later....
Just do not despair. We hold a great share which is fulfilling all what is required to appreciate its value and sp will catch up with all hidden inside this gem.
All comes in time but more patience is required and good level op..$70+
Dividends on 24/6 ?
Lots of drilling...gas on the horizon, M&A possibilities, growth of oil production etc etc...
Still holding Big ,and added a few recently on the dip...keep faith
Good luck all ....great posters here and thank you for the congratulations .

Thank you Ocelot..
It is a great honour to be a joint winner with Mayor bunks and would like to pass the honours of speech to him to enlighten us of his words of wisdom on our beloved Genl...

Kettle..
It is the Automatic dealings of the same request either buy or sell but mm and stockbroker cannot complete the request in one go so it completes in two or more go. Dealing costs the same as if it is one but fragmented.